智通财经APP讯，爱康医疗(01789)发布截至2025年12月31日止年度业绩，该集团取得收入人民币14.82亿元(单位下同)，同比增加10.1%;公司权益股东应占年度溢利3.39亿元，同比增加23.8%;每股基本盈利0.304元，拟派发末期股息每股11.8港仙。
2025年，在带量采购政策推动下，进一步加速进口替代，公司产品的手术量需求持续增长。手术量快速增长，以及在数字骨科全流程解决方案的带动下，进一步提升了公司产品在医院的覆盖率，也使得公司产品销售获得进一步增长。同时，本集团通过积极的市场开拓，海外收入以及数字骨科智能产品及服务也获得显著增长。本集团截至2025年12月31日止年度实现净利润人民币 3.39亿元，较2024年同期显著增长23.8%。溢利显著增长主要归因于收入增长以及海外及数字骨科定制产品及服务收入提升带来的毛利率提升的影响所致。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.